American Lung Association

Dr. Castro defines type 2 inflammation and the complications surrounding severe asthma, as well as several biomarkers including IgE levels, blood eosinophils, and exhaled nitric oxide.

Dr. Castro and Dr. Rizzo discuss the evolving world of monoclonal antibodies for severe asthma. Plus, the ALA team discusses September's annual Asthma Peak Week, and what it means for reopening schools.

Dr. Mazzocchi talks of the promising new cancer care therapies and how to properly inform and care for patients with cancer who may be overwhelmed.

Dr. Mazzocchi discusses the limits and benefits of immunotherapies, as well as the importance of genetic testing in determining cancer diagnosis and treatment in patients.

The co-founder and CEO of Known Medicine dissects the art and science of how profiling biomarkers, epigenetics and the microenvironment may provide the synergy needed to revolutionize the oncologic landscape.

The National Institutes of Health expert and research joins to discuss the evolving understanding of vaping devices and effects.

An expert discussion on categorizing climate change and the impact it will have on health in communities across the globe.

An expert discussion on climate change and air pollution effects on communities, including increased COVID-19 rates.

Climate change health experts Poune Saberi, MD, and Alan S. Greenglass, MD, join Lungcast for a timely discussion on environmental health issues.

A trio of experts from the Cleveland Clinic join Dr. Rizzo for a talk on lung transplant trends and challenges in the US.

In commemoration of World TB Day, a CDC and ALA expert discuss how TB still exists in the country.

CDC tuberculosis lead Dr. Phillip LoBue joins to discuss the past and present issues of the disease, in time for TB Awareness Day on March 24.

Uncovering the zoological host that first transmitted the virus to humans could inform factors relevant to this pandemic—and the next one.

An expert weighs in on the strengths, makeup, and timeframe of current and upcoming vaccine options.

A conversation with an expert virologist and public health advocate on the scientific and societal machinations of COVID-19 vaccination.

Anne Dixon, MD, explains how it took 6 years to update recommendations for new asthma therapies.

A conversation on how associations between the chronic conditions have become better understood in 10 years.

A discussion around obesity's effect on asthma, and the newest recommendations for managed care.

The last episode of 2020 caps advances and ongoing research into the most burdensome chronic respiratory disease in the US.

Lung cancer interception research and strategies are trying to make up ground on the often-missed risk group.

A team of researchers share strategies to "map out" pre-cancer lung risks in their greater goal of interception.

A dual-guest interview on the current leading research into advanced lung cancer screening and detection.

Dr. Fauci gives perspective on the future presence of the virus, improving US pandemic preparedness, and the theological divisions which have plagued national response.

What the potential of monoclonal antibodies may be, and what's currently understood about serologic antibodies.

Fauci shares his thoughts on leading COVID-19 vaccines, SARS-CoV-2 transmission, antibody research, and where the US went wrong in pandemic response.

Low annual donor use and high mortality rates could be correlatively improved with greater embrace of opportunities.

The chief of thoracic surgery and surgical director of the Northwestern Medicine Lung Transplant Program discusses his unprecedented procedure during the pandemic.

A famed virologist weighs in on the country's earliest shortcomings—and how they can still be resolved today.

World-leading virologist and AIDS researcher David Ho, MD, joins the inaugural podcast episode.

ALA chief medical officer Al Rizzo, MD, discusses plans to kickstart vaccine research and public health preventive measures.